Caplacizumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06081 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | pseudo-von Willebrand disease | KG + DL |
| 3 | Glanzmann thrombasthenia | KG + DL |
| 4 | Scott syndrome | KG + DL |
| 5 | thrombotic thrombocytopenic purpura | KG + DL |
| 6 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 7 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 8 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 9 | hemophilia | KG + DL |
| 10 | platelet-type bleeding disorder | KG + DL |
| 11 | acquired coagulation factor deficiency | KG + DL |
| 12 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 13 | inherited thrombophilia | KG + DL |
| 14 | flood factor deficiency | KG + DL |
| 15 | symptomatic form of hemophilia in female carriers | KG + DL |
| 16 | congenital factor V deficiency | KG + DL |
| 17 | hereditary thrombocytosis with transverse limb defect | KG + DL |
| 18 | familial thrombomodulin anomalies | KG + DL |
| 19 | methylcobalamin deficiency type cblG | KG + DL |
| 20 | hemophilia A with vascular abnormality | KG + DL |
| 21 | atypical hemolytic-uremic syndrome with thrombomodulin anomaly | KG + DL |
| 22 | neuropathy, painful | KG + DL |
| 23 | peliosis hepatis | KG + DL |
| 24 | factor XI deficiency | KG + DL |
| 25 | hepatic infarction | KG + DL |
| 26 | TAFRO syndrome | KG + DL |
| 27 | Peyronie disease | KG + DL |
| 28 | autosomal dominant macrothrombocytopenia | KG + DL |
| 29 | acquired hemophilia | KG + DL |
| 30 | hepatic veno-occlusive disease | KG + DL |
| 31 | penile fibromatosis | KG + DL |
| 32 | cyclic hematopoiesis | KG + DL |
| 33 | hemorrhagic disorder due to a platelet anomaly | KG + DL |
| 34 | Ledderhose disease | KG + DL |
| 35 | infantile digital fibromatosis | KG + DL |
| 36 | factor XIII, A subunit, deficiency | KG + DL |
| 37 | X-linked severe congenital neutropenia | KG + DL |
| 38 | adult idiopathic neutropenia | KG + DL |
| 39 | congenital factor XIII deficiency | KG + DL |
| 40 | syndrome with combined immunodeficiency | KG + DL |
| 41 | Von Willebrand disease, X-linked form | KG + DL |
| 42 | Evans syndrome | KG + DL |
| 43 | palmar fibromatosis | KG + DL |
| 44 | von Willebrand disease | KG + DL |
| 45 | inherited prekallikrein deficiency | KG + DL |
| 46 | posterior leukoencephalopathy syndrome | KG + DL |
| 47 | hemorrhagic disorder due to a coagulation factors defect | KG + DL |
| 48 | autosomal recessive severe congenital neutropenia due to JAGN1 deficiency | KG + DL |
| 49 | congenital neutropenia-myelofibrosis-nephromegaly syndrome | KG + DL |
| 50 | Camurati-Engelmann disease | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.